Jeffrey S Mathiesen insider trades
Open-market stock purchases and sales by Jeffrey S Mathiesen, Director at NEUROONE MEDICAL TECHNOLOGIES Corp, from SEC Form 4 filings since Nov 12, 2012.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -61%.
Companies traded
- NMTC NEUROONE MEDICAL TECHNOLOGIES Corp: other filings, last Apr 3, 2026
- HSDT Helius Medical Technologies, Inc: 1 buy, last Jul 2, 2025
- PBLA Panbela Therapeutics, Inc: other filings, last Mar 27, 2023
- SNBP Sun BioPharma, Inc: 1 buy, last Jun 24, 2020
- GEMP Gemphire Therapeutics Inc: 1 buy, last Jan 28, 2018
- SSH Sunshine Heart, Inc: 1 buy, last Jan 1, 2015
Get free alerts when Jeffrey S Mathiesen files a new trade →